A pharmacy technician compounds a tretinoin oral suspension and finds that the drug pamphlet does not provide instruction for assigning a beyond-use date. The technician should refer to beyond-use dating guidelines found in USP Chapter:

Chapter 37 of the USP does not specifically address beyond-use dating; instead, it pertains to the general aspects of pharmaceutical compounding and quality control. While relevant to compounding practices, it lacks the focused guidelines necessary for determining beyond-use dates for compounded nonsterile preparations.

USP Chapter 797 focuses on sterile compounding and the standards necessary to ensure the safety and effectiveness of sterile products. While it addresses important aspects of compounding practices, it does not provide guidance on beyond-use dating for nonsterile preparations, thus making it irrelevant to the technician’s inquiry.

Chapter 800 outlines the handling of hazardous drugs in healthcare settings, including compounding and administration precautions. This chapter is essential for ensuring safety when working with such drugs, but it does not cover beyond-use dating guidelines for compounded medications, making it unsuitable for this situation.